Share
Market Research Report

COMPANION ANIMAL VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeAttenuated Live Vaccine · Conjugate Vaccine · Inactivated Vaccine · Subunit Vaccine · Toxoid Vaccine · DNA Vaccine · Recombinant Vaccine
  • By Species TypeCanine · Feline · Equine · Avians · and Others
  • By Distribution ChannelVeterinary Clinics · Veterinary Hospitals · Veterinary Research Institutes and Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In31 Mar 2026
  • Report CodeCMI3387
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Species Type
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Product Launches/Approvals
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Companion Animal Vaccine Market, By Product Type, 2021– 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Attenuated Live Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Conjugate Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Inactivated Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Subunit Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Toxoid Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • DNA Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trend
    • Recombinant Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trend
  5. Global Companion Animal Vaccine Market, By Species Type, 2021– 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Canine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Feline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Equine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Avians
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
      • Segment Trends
  6. Global Companion Animal Vaccine Market, By Distribution Channel, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Veterinary Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Veterinary Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Veterinary Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
  7. Global Companion Animal Vaccine Market, By Region, 2021 – 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 –2033, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Elanco Animal Health Incorporated
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Boehringer Ingelheim GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Ceva Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Virbac
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Zoetis Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • HIPRA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biogénesis Bagó
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Ourofino Animal Health.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Croda International Plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • KM Biologics
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Indian Immunologicals Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sinovac
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Kyoto Biken Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • HESTER BIOSCIENCES LIMITED
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Calier
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bioveta, a.s
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact